Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Hologic/Grifols, Roche Molecular Zika Tests Tapped For Blood-Screening Ramp-Up

Executive Summary

A blood-screening test made by Hologic in collaboration with Grifols, and another made by Roche Molecular Diagnostics, are being used in a gradual ramp-up of Zika virus screening at blood donation centers across the US under a new FDA program.


Related Content

FDA Approves Roche Molecular Cobas Test As Zika Virus Blood Donor Screen
Blood Brothers No More: Hologic Unloads Blood-Screening Business To Partner Grifols
Short-Term US Funding Bill Passes With $1.1bn In Emergency Zika Funds
Zika Assay Reviews Are Testing The Limits Of FDA Capacity, Shuren Says
Hologic Wins $4.1m To Advance Zika Blood Screen
Manufacturer Doesn’t Expect Zika Blood-Screening Test Shortage
House-Senate Conferees Fight Over Zika Funds As FDA Approves More Assays





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts